The present invention provides methods for the treatment of an endobronchial infection in a patient by administering to the endobronchial system of the patient a dry powder aerosol composition comprising from 90 to 130 mg of an aminoglycoside antibiotic one to three times a day for a first treatment period of 20 to 36 days.
申请公布号
CA2570976(C)
申请公布日期
2013.08.13
申请号
CA20052570976
申请日期
2005.06.20
申请人
NOVARTIS VACCINES AND DIAGNOSTICS, INC.;NEKTAR THERAPEUTICS
发明人
CHALLONER, PETER;RODRIGUEZ, CARLOS;TARARA, THOMAS E.;LORD, JOHN D.;SAMARA, EMIL
